|
Real-time Estimate
Cboe BZX
01:29:59 02/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 5.255 USD | +1.25% |
|
0.00% | +2.34% |
| 01/09 | Alvotech Shares Rise After FDA Accepts Biologics License Application for AVT80 | MT |
| 31/08 | Alvotech's Application for Proposed Entyvio Biosimilar Accepted for US FDA Review | MT |
| Market Cap | 185.24Cr 159.79Cr 150.3Cr 136.93Cr 257.49Cr 18TCr 258.89Cr 1.78TCr 691.6Cr 8.94TCr 695.47Cr 680.4Cr 30TCr | P/E 2026 * |
99.8x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 292.93Cr 252.68Cr 237.68Cr 216.53Cr 407.19Cr 28TCr 409.39Cr 2.81TCr 1.09TCr 14TCr 1.1TCr 1.08TCr 47TCr | EV / Sales 2026 * |
4.44x | EV / Sales 2027 * | 3.75x |
| Free-Float |
45.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Alvotech
| 1 day | +1.16% | ||
| Current month | +1.16% | ||
| 1 month | +27.43% | ||
| 3 months | +56.25% | ||
| 6 months | +31.58% | ||
| Current year | +2.34% |
| 1 week | 4.78 |  | 5.26 |
| 1 month | 3.67 | | 5.39 |
| Current year | 2.94 | | 5.58 |
| 1 year | 2.94 | | 9.25 |
| 3 years | 2.94 | | 18 |
| 5 years | 2.94 | | 18 |
| 10 years | 2.94 | | 18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lisa Graver
CEO | Chief Executive Officer | 55 | 01/03/2026 |
Linda Jonsdottir
DFI | Director of Finance/CFO | 48 | 10/07/2025 |
Giedrius Zunda
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Vilhelm Wessman
CHM | Chairman | 56 | 01/01/2019 |
Richard Davies
BRD | Director/Board Member | 64 | 01/01/2019 |
Tomas Ekman
BRD | Director/Board Member | 58 | 01/01/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/04/26 | Free | Chief Executive Officer | 1,17,271 | 0.0355% | ||
| 01/04/26 | Sell | Founder | 3,18,000 | 0.0963% | ||
| 01/04/26 | Buy | Founder | 3,18,000 | 0.0963% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.25% | 0.00% | -34.94% | -46.97% | 185.24Cr | |
| +0.21% | -1.70% | +1.90% | +18.18% | 4.98TCr | |
| +2.09% | -0.81% | +452.73% | +517.81% | 4.41TCr | |
| -1.09% | -0.73% | +35.40% | +16.04% | 4.3TCr | |
| -0.26% | -3.58% | +17.19% | +72.80% | 4.09TCr | |
| -0.48% | -3.09% | +17.78% | +49.80% | 3.31TCr | |
| -1.81% | -5.94% | +22.65% | +115.79% | 1.66TCr | |
| -1.06% | +3.29% | - | - | 1.73TCr | |
| -1.35% | -2.32% | +10.40% | +25.90% | 1.46TCr | |
| -2.05% | -5.44% | +72.89% | +36.51% | 1.38TCr | |
| Average | -0.43% | -0.78% | +66.22% | +89.54% | 2.75TCr | |
| Weighted average by Cap. | -0.18% | -1.73% | +94.39% | +123.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 66Cr 57Cr 53Cr 49Cr 92Cr 6.26TCr 92Cr 632.45Cr 246.16Cr 3.18TCr 247.54Cr 242.18Cr 11TCr | 78Cr 67Cr 63Cr 57Cr 107.83Cr 7.36TCr 108.41Cr 744.07Cr 289.61Cr 3.74TCr 291.23Cr 284.92Cr 12TCr |
| Net income | 3.04Cr 2.62Cr 2.46Cr 2.24Cr 4.22Cr 288.14Cr 4.24Cr 29Cr 11Cr 146.57Cr 11Cr 11Cr 486.01Cr | 11Cr 9.41Cr 8.85Cr 8.07Cr 15Cr 1.04TCr 15Cr 104.66Cr 41Cr 526.74Cr 41Cr 40Cr 1.75TCr |
| Net Debt | 107.69Cr 93Cr 87Cr 80Cr 149.69Cr 10TCr 150.5Cr 1.03TCr 402.06Cr 5.2TCr 404.31Cr 395.55Cr 17TCr | 105.72Cr 91Cr 86Cr 78Cr 146.95Cr 10TCr 147.75Cr 1.01TCr 394.7Cr 5.1TCr 396.91Cr 388.3Cr 17TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/26/01 | $5.250 | +1.16% | 10,28,884 |
| 31/26/31 | $5.190 | +4.85% | 12,50,839 |
| 28/26/28 | $4.950 | +1.43% | 8,78,459 |
| 27/26/27 | $4.880 | -0.61% | 9,67,686 |
| 26/26/26 | $4.910 | -2.77% | 8,90,179 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALVO Stock
Select your edition
All financial news and data tailored to specific country editions
